Next Generation Sequencing Market Research Report - Forecast till 2030

Next Generation Sequencing Market Research Report Information by Technology (Whole Exome Sequencing, Targeted Sequencing and Resequencing [DNA-based Targeted Sequencing & Resequencing and RNA-based Targeted Sequencing & Resequencing], and Whole Genome Sequencing), by Workflow (Pre-sequencing [NGS Library Preparation Kits, NGS Semi-Automated Library Preparation Kits, NGS Automated Library Preparation Kits, and Clonal Amplification], Sequencing, Data Analysis [NGS Primary Data Analysis, NGS Secondary Data Analysis, and NGS Tertiary Data Analy

ID: MRFR/LS/4893-HCR | 90 Pages | Author: Rahul Gotadki | February 2024         

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY TECHNOLOGY

6.1. Overview

6.2. Targeted Sequencing and Resequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. DNA-based Targeted Sequencing and Resequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2. RNA-based Targeted Sequencing and Resequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Whole Genome Sequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Whole Exome Sequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY WORKFLOW

7.1. Overview

7.2. Pre-Sequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.1. NGS Library Preparation Kits

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.2. NGS Semi-Automated Library Preparation Kits

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.3. NGS Automated Library Preparation Kits

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.4. Clonal Amplification

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Sequencing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Data Analysis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4.1. NGS Primary Data Analysis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4.2. NGS Secondary Data Analysis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4.3. NGS Tertiary Data Analysis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY APPLICATION

8.1. Overview

8.2. Oncology

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.2.1. Diagnostics and Screening

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.2.2. Oncology Screening

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.2.3. Companion Diagnostics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.2.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Clinical Investigation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3.1. Infectious Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3.2. Inherited Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3.3. Idiopathic Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3.4. Non-Communicable Diseases

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3.5. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Reproductive Health

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4.1. Non-invasive Prenatal Testing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4.2. Pre-implantation Genetic Testing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4.3. Newborn or Genetic Screening

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4.4. Single Gene Analysis

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4.5. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5. Human Leukocyte Antigen Typing or Immune System Monitoring

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.6. Metagenomics, Epidemiology and Drug Development

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.7. Agrigenomics and Forensics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.8. Consumer Genomics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.9. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY END USER

9.1. Overview

9.2. Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3. Diagnostic Laboratories

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4. Pharmaceutical and Biotechnology Companies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

10. GLOBAL NEXT GENERATION SEQUENCING MARKET, BY REGION

10.1. Overview

10.2. Americas

10.2.1. North America

10.2.1.1. US

10.2.1.2. Canada

10.2.2. Latin America

10.3. Europe

10.3.1. Western Europe

10.3.1.1. Germany

10.3.1.2. France

10.3.1.3. Italy

10.3.1.4. Spain

10.3.1.5. UK

10.3.1.6. Rest of Western Europe

10.3.2. Eastern Europe

10.4. Asia-Pacific

10.4.1. Japan

10.4.2. China

10.4.3. India

10.4.4. Australia

10.4.5. South Korea

10.4.6. Rest of Asia-Pacific

10.5. Middle East & Africa

10.5.1. Middle East

10.5.2. Africa

11. COMPANY LANDSCAPE

11.1. Overview

11.2. Competitive Analysis

11.3. Market Share Analysis

11.4. Major Growth Strategies in the Global Next Generation Sequencing Market

11.5. Competitive Benchmarking

11.6. Leading Players in Terms of Number of Developments in the Global Next Generation Sequencing Market

11.7. Key Developments and Growth Strategies

11.7.1. Product Launch/Service Deployment

11.7.2. Mergers and Acquisitions

11.7.3. Joint Ventures

11.8. Major Players Financial Matrix & Market Ratio

11.8.1. Sales & Operating Income 2020

11.8.2. Major Players R&D Expenditure 2020

11.9. Major Players Capital Market Ratio

12. COMPANY PROFILES

12.1. Agilent Technologies, Inc.

12.1.1. Company Overview

12.1.2. Product Overview

12.1.3. Financial Overview

12.1.4. Key Developments

12.1.5. SWOT Analysis

12.1.6. Key Strategies

12.2. Eurofins Scientific

12.2.1. Company Overview

12.2.2. Product Overview

12.2.3. Financial Overview

12.2.4. Key Developments

12.2.5. SWOT Analysis

12.2.6. Key Strategies

12.3. Genome Life Sciences

12.3.1. Company Overview

12.3.2. Product Overview

12.3.3. Financial Overview

12.3.4. Key Developments

12.3.5. SWOT Analysis

12.3.6. Key Strategies

12.4. GenScript

12.4.1. Company Overview

12.4.2. Product Overview

12.4.3. Financial Overview

12.4.4. Key Developments

12.4.5. SWOT Analysis

12.4.6. Key Strategies

12.5. Illumina, Inc.

12.5.1. Company Overview

12.5.2. Product Overview

12.5.3. Financial Overview

12.5.4. Key Developments

12.5.5. SWOT Analysis

12.5.6. Key Strategies

12.6. Thermo Fisher Scientific

12.6.1. Company Overview

12.6.2. Product Overview

12.6.3. Financial Overview

12.6.4. Key Developments

12.6.5. SWOT Analysis

12.6.6. Key Strategies

12.7. Qiagen

12.7.1. Company Overview

12.7.2. Product Overview

12.7.3. Financial Overview

12.7.4. Key Developments

12.7.5. SWOT Analysis

12.7.6. Key Strategies

12.8. PerkinElmer Inc.

12.8.1. Company Overview

12.8.2. Product Overview

12.8.3. Financial Overview

12.8.4. Key Developments

12.8.5. SWOT Analysis

12.8.6. Key Strategies

12.9. F. Hoffmann-La Roche Ltd

12.9.1. Company Overview

12.9.2. Product Overview

12.9.3. Financial Overview

12.9.4. Key Developments

12.9.5. SWOT Analysis

12.9.6. Key Strategies

12.10. Pacific Biosciences of California, Inc.

12.10.1. Company Overview

12.10.2. Product Overview

12.10.3. Financial Overview

12.10.4. Key Developments

12.10.5. SWOT Analysis

12.10.6. Key Strategies

12.11. Xcelris Genomics

12.11.1. Company Overview

12.11.2. Product Overview

12.11.3. Financial Overview

12.11.4. Key Developments

12.11.5. SWOT Analysis

12.11.6. Key Strategies

12.12. Macrogen, Inc.

12.12.1. Company Overview

12.12.2. Product Overview

12.12.3. Financial Overview

12.12.4. Key Developments

12.12.5. SWOT Analysis

12.12.6. Key Strategies

12.13. BGI

12.13.1. Company Overview

12.13.2. Product Overview

12.13.3. Financial Overview

12.13.4. Key Developments

12.13.5. SWOT Analysis

12.13.6. Key Strategies

12.14. Charles River

12.14.1. Company Overview

12.14.2. Product Overview

12.14.3. Financial Overview

12.14.4. Key Developments

12.14.5. SWOT Analysis

12.14.6. Key Strategies

12.15. Oxford Nanopore Technologies

12.15.1. Company Overview

12.15.2. Product Overview

12.15.3. Financial Overview

12.15.4. Key Developments

12.15.5. SWOT Analysis

12.15.6. Key Strategies

12.16. Others

13. APPENDIX

13.1. References

13.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL NEXT GENERATION SEQUENCING MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL NEXT GENERATION SEQUENCING MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY TYPE OF SEQUENCING, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 6 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 7 GLOBAL NEXT GENERATION SEQUENCING MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 8 NORTH AMERICA: NEXT GENERATION SEQUENCING MARKET, BY TYPE OF SEQUENCING, 2020-2027 (USD MILLION)

TABLE 9 NORTH AMERICA: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 10 NORTH AMERICA: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 11 NORTH AMERICA: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 12 US: NEXT GENERATION SEQUENCING MARKET, BY TYPE OF SEQUENCING, 2020-2027 (USD MILLION)

TABLE 13 US: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 14 US: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 15 US: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 16 CANADA: NEXT GENERATION SEQUENCING MARKET, BY TYPE OF SEQUENCING, 2020-2027 (USD MILLION)

TABLE 17 CANADA: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 18 CANADA: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 19 CANADA: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 20 LATIN AMERICA: NEXT GENERATION SEQUENCING MARKET, BY TYPE OF SEQUENCING, 2020-2027 (USD MILLION)

TABLE 21 LATIN AMERICA: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 22 LATIN AMERICA: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 23 LATIN AMERICA: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 24 EUROPE: NEXT GENERATION SEQUENCING MARKET, BY TYPE OF SEQUENCING, 2020-2027 (USD MILLION)

TABLE 25 EUROPE: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 26 EUROPE: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 27 EUROPE: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 28 WESTERN EUROPE: NEXT GENERATION SEQUENCING MARKET, BY TYPE OF SEQUENCING, 2020-2027 (USD MILLION)

TABLE 29 WESTERN EUROPE: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 30 WESTERN EUROPE: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 31 WESTERN EUROPE: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 32 EASTERN EUROPE: NEXT GENERATION SEQUENCING MARKET, BY TYPE OF SEQUENCING, 2020-2027 (USD MILLION)

TABLE 33 EASTERN EUROPE: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 34 EASTERN EUROPE: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 35 EASTERN EUROPE: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 36 ASIA-PACIFIC: NEXT GENERATION SEQUENCING MARKET, BY TYPE OF SEQUENCING, 2020-2027 (USD MILLION)

TABLE 37 ASIA-PACIFIC: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 38 ASIA-PACIFIC: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 39 ASIA-PACIFIC: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA: NEXT GENERATION SEQUENCING MARKET, BY TYPE OF SEQUENCING, 2020-2027 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA: NEXT GENERATION SEQUENCING MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA: NEXT GENERATION SEQUENCING MARKET, BY APPLICATION, 2020-2027 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA: NEXT GENERATION SEQUENCING MARKET, BY END USER, 2020-2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE OF THE GLOBAL NEXT GENERATION SEQUENCING MARKET

FIGURE 3 MARKET DYNAMICS OF THE GLOBAL NEXT GENERATION SEQUENCING MARKET

FIGURE 4 GLOBAL NEXT GENERATION SEQUENCING MARKET SHARE, BY TYPE OF SEQUENCING, 2020 (%)

FIGURE 5 GLOBAL NEXT GENERATION SEQUENCING MARKET SHARE, BY PRODUCT TYPE, 2020 (%)

FIGURE 6 GLOBAL NEXT GENERATION SEQUENCING MARKET SHARE, BY APPLICATION, 2020 (%)

FIGURE 7 GLOBAL NEXT GENERATION SEQUENCING MARKET SHARE, BY END USER, 2020 (%)

FIGURE 8 GLOBAL NEXT GENERATION SEQUENCING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 AMERICAS: NEXT GENERATION SEQUENCING MARKET SHARE BY REGION, 2020 (%)

FIGURE 9 NORTH AMERICA: NEXT GENERATION SEQUENCING MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 10 EUROPE: NEXT GENERATION SEQUENCING MARKET SHARE, BY REGION, 2020 (%)

FIGURE 11 WESTERN EUROPE: NEXT GENERATION SEQUENCING MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 ASIA-PACIFIC: NEXT GENERATION SEQUENCING MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 MIDDLE EAST & AFRICA: NEXT GENERATION SEQUENCING MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 14 GLOBAL NEXT GENERATION SEQUENCING MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 15 AGILENT TECHNOLOGIES, INC..: KEY FINANCIALS

FIGURE 16 AGILENT TECHNOLOGIES, INC.: SEGMENTAL REVENUE

FIGURE 17 AGILENT TECHNOLOGIES, INC.: REGIONAL REVENUE

FIGURE 18 EUROFINS SCIENTIFIC: KEY FINANCIALS

FIGURE 19 EUROFINS SCIENTIFIC: SEGMENTAL REVENUE

FIGURE 20 EUROFINS SCIENTIFIC: REGIONAL REVENUE

FIGURE 21 GENOME LIFE SCIENCES: KEY FINANCIALS

FIGURE 22 GENOME LIFE SCIENCES: SEGMENTAL REVENUE

FIGURE 23 GENOME LIFE SCIENCES: REGIONAL REVENUE

FIGURE 24 GENSCRIPT: KEY FINANCIALS

FIGURE 25 GENSCRIPT: SEGMENTAL REVENUE

FIGURE 26 GENSCRIPT: REGIONAL REVENUE

FIGURE 27 ILLUMINA, INC.: KEY FINANCIALS

FIGURE 28 ILLUMINA, INC.: SEGMENTAL REVENUE

FIGURE 29 ILLUMINA, INC.: REGIONAL REVENUE

FIGURE 30 THERMO FISHER SCIENTIFIC: KEY FINANCIALS

FIGURE 31 THERMO FISHER SCIENTIFIC: SEGMENTAL REVENUE

FIGURE 32 THERMO FISHER SCIENTIFIC: REGIONAL REVENUE

FIGURE 33 QIAGEN: KEY FINANCIALS

FIGURE 34 QIAGEN: SEGMENTAL REVENUE

FIGURE 35 QIAGEN: REGIONAL REVENUE

FIGURE 36 PERKINELMER INC.: KEY FINANCIALS

FIGURE 37 PERKINELMER INC.: SEGMENTAL REVENUE

FIGURE 38 PERKINELMER INC.: REGIONAL REVENUE

FIGURE 39 F. HOFFMANN-LA ROCHE LTD: KEY FINANCIALS

FIGURE 40 F. HOFFMANN-LA ROCHE LTD: SEGMENTAL REVENUE

FIGURE 41 F. HOFFMANN-LA ROCHE LTD: REGIONAL REVENUE

FIGURE 42 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: KEY FINANCIALS

FIGURE 43 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: SEGMENTAL REVENUE

FIGURE 44 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: REGIONAL REVENUE

FIGURE 45 XCELRIS GENOMICS: KEY FINANCIALS

FIGURE 46 XCELRIS GENOMICS: SEGMENTAL REVENUE

FIGURE 47 XCELRIS GENOMICS: REGIONAL REVENUE

FIGURE 48 MACROGEN, INC.: KEY FINANCIALS

FIGURE 49 MACROGEN, INC.: SEGMENTAL REVENUE

FIGURE 50 MACROGEN, INC.: REGIONAL REVENUE

FIGURE 51 BGI: KEY FINANCIALS

FIGURE 52 BGI: SEGMENTAL REVENUE

FIGURE 53 BGI: REGIONAL REVENUE

FIGURE 54 CHARLES RIVER: KEY FINANCIALS

FIGURE 55 CHARLES RIVER: SEGMENTAL REVENUE

FIGURE 56 CHARLES RIVER: REGIONAL REVENUE

FIGURE 57 OXFORD NANOPORE TECHNOLOGIES: KEY FINANCIALS

FIGURE 58 OXFORD NANOPORE TECHNOLOGIES: SEGMENTAL REVENUE

FIGURE 59 OXFORD NANOPORE TECHNOLOGIES: REGIONAL REVENUE

Market Segmentation For Next Generstion Sequencing Market


Next Generation Technology Outlook (USD Billion, 2018-2030)




  • Whole Exome Sequencing




  • Targeted Sequencing and Resequencing




    • DNA-based Targeted Sequencing & Resequencing




    • RNA-based Targeted Sequencing & Resequencing






  • Whole Genome Sequencing




Next Generation Workflow Outlook (USD Billion, 2018-2030)




  • Pre-sequencing




    • NGS Library Preparation Kits




    • NGS Semi-Automated Library Preparation Kits




    • NGS Automated Library Preparation Kits




    • Clonal Amplification






  • Sequencing




  • Data Analysis




    • NGS Primary Data Analysis




    • NGS Secondary Data Analysis




    • NGS Tertiary Data Analysis






Next Generation Application Outlook (USD Billion, 2018-2030)




  • Oncology




    • Diagnostics and Screening




    • Companion Diagnostics




    • Others






  • Clinical Investigation




    • Infectious Diseases




    • Inherited Diseases




    • Idiopathic Diseases




    • Non-Communicable Diseases




    • Others






  • Reproductive Health




    • Non-invasive Prenatal Testing




    • Pre-implantation Genetic Testing




    • Newborn or Genetic Screening




    • Single Gene Analysis




    • Others






  • Human Leukocyte Antigen Typing or Immune System Monitoring




  • Metagenomics, Epidemiology and Drug Development




  • Agrigenomics and Forensics




  • Consumer Genomics




  • Others




Next Generation End User Outlook (USD Billion, 2018-2030)




  • Hospitals & Clinics




  • Diagnostic Laboratories




  • Pharmaceutical and Biotechnology Companies




  • Academic and Research Institutes




Next Generation Regional Outlook (USD Billion, 2018-2030)




  • North America Outlook (USD Billion, 2018-2030)




    • North America Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • North America Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • North America Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • North America Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • US Outlook (USD Billion, 2018-2030)




    • US Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • US Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • US Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • US Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • CANADA Outlook (USD Billion, 2018-2030)




    • Canada Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • Canada Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • Canada Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • Canada Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes








  • Europe Outlook (USD Billion, 2018-2030)




    • Europe Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • Europe Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • Europe Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • Europe Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • Germany Outlook (USD Billion, 2018-2030)




    • Germany Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • Germany Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • Germany Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • Germany Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • France Outlook (USD Billion, 2018-2030)




    • France Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • France Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • France Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • France Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • UK Outlook (USD Billion, 2018-2030)




    • UK Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • UK Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • UK Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • UK Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • Italy Outlook (USD Billion, 2018-2030)




    • Italy Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • Italy Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • Italy Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • Italy Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes














    • Spain Outlook (USD Billion, 2018-2030)




    • Spain Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • Spain Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • Spain Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • Spain Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • Rest Of Europe Outlook (USD Billion, 2018-2030)




    • Spain Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • Spain Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • Spain Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • Spain Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes







  • Asia-Pacific Outlook (USD Billion, 2018-2030)




    • Asia-Pacific Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • Asia-Pacific Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • Asia-Pacific Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • Asia-Pacific Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • Japan Outlook (USD Billion, 2018-2030)




    • Japan Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • Japan Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • Japan Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • Japan Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • India Outlook (USD Billion, 2018-2030)




    • India Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • India Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • India Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • India Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • South Korea Outlook (USD Billion, 2018-2030)




    • South Korea Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • South Korea Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • South Korea Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • South Korea Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • Australia Outlook (USD Billion, 2018-2030)




    • Australia Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • Australia Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • Australia Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • Australia Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)




    • Rest of Asia-Pacific Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • Rest of Asia-Pacific Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • Rest of Asia-Pacific Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • Rest of Asia-Pacific Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes








  • Rest of the World Outlook (USD Billion, 2018-2030)




    • Rest of World Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • Rest of World Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • Rest of World Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • Rest of World Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • Middle East Outlook (USD Billion, 2018-2030)




    • Middle East Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • Middle East Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • Middle East Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • Middle East Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • Africa Outlook (USD Billion, 2018-2030)




    • Africa Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • Africa Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • Africa Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • Africa Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes






    • Latin America Outlook (USD Billion, 2018-2030)




    • Latin America Next Generation by Technology




      • Whole Exome Sequencing




      • Targeted Sequencing and Resequencing




        • DNA-based Targeted Sequencing & Resequencing




        • RNA-based Targeted Sequencing & Resequencing






      • Whole Genome Sequencing






    • Latin America Next Generation by Workflow




      • Pre-sequencing




        • NGS Library Preparation Kits




        • NGS Semi-Automated Library Preparation Kits




        • NGS Automated Library Preparation Kits




        • Clonal Amplification






      • Sequencing




      • Data Analysis




        • NGS Primary Data Analysis




        • NGS Secondary Data Analysis




        • NGS Tertiary Data Analysis








    • Latin America Next Generation by Application




      • Oncology




        • Diagnostics and Screening




        • Companion Diagnostics




        • Others






      • Clinical Investigation




        • Infectious Diseases




        • Inherited Diseases




        • Idiopathic Diseases




        • Non-Communicable Diseases




        • Others






      • Reproductive Health




        • Non-invasive Prenatal Testing




        • Pre-implantation Genetic Testing




        • Newborn or Genetic Screening




        • Single Gene Analysis




        • Others






      • Human Leukocyte Antigen Typing or Immune System Monitoring




      • Metagenomics, Epidemiology and Drug Development




      • Agrigenomics and Forensics




      • Consumer Genomics




      • Others






    • Latin America Next Generation by End User




      • Hospitals & Clinics




      • Diagnostic Laboratories




      • Pharmaceutical and Biotechnology Companies




      • Academic and Research Institutes







Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid

Research methodology on Next Generation Sequencing market


Abstract


The objective of this research is to provide an in-depth analysis of the Next Generation Sequencing market through a comprehensive assessment of the various components of the market including market trends, current market scenarios, product innovation and other factors providing growth insights. Additionally, the report provides an in-depth analysis of the market dynamics, key strategies adopted by the major players and their competitive environment. It also presents the overall impact of various developments in the Next Generation Sequencing market on the growth of the market.


Introduction


The Next Generation Sequencing (NGS) market is rapidly evolving and is expected to achieve significant growth over the forecast period 2023 to 2030. NGS is a revolutionary step forward in genomic analysis and is leading the way to a new generation of DNA sequencing technologies. With advancements in sequencing technology over the years, NGS has become a more viable option for new applications in research, diagnostics, personalized medicine and more. Through further technological advancements and the increasing use of NGS in research, diagnostics and clinical application development, this field has become one of the most valuable markets in the world. With its rising potential, the market offers several opportunities for stakeholders to gain a superior competitive edge over its competitors. The present report outlines the various research insights into the NGS market.


Research Methodology


The Next Generation Sequencing (NGS) market is researched through a multifaceted research methodology. This includes both primary and secondary research. The primary research portion involves both primary and secondary research such as interviews and market surveys. On the other hand, secondary research is conducted through market research publications, systematic reviews, online databases, news items and industry reports.


For market assessment, the primary research data is supplemented with relevant data such as company profile, market size, revenue growth and application segments. The primary research is based on discussions with various stakeholders including research and development experts, scientists, healthcare professionals, patients and patient groups, distributors, vendors, service providers, industry experts and senior executives from the NGS industry.


Additionally, a comprehensive market analysis of the NGS market is conducted through both primary and secondary research to understand the current trends, competitive dynamics and market size. The market size is calculated by considering the revenue generated within the NGS market across multiple sources for the present and forecast periods. The research also includes desk-based research to gain information about the major contenders in the market, their products and other key developments. Furthermore, secondary data is collected through websites, interviews and press releases to assess the competitive landscape of the market. The report also includes interview-based data to create an understanding of the competitive landscape, industry trends, technological advancements, competitive dynamics and prevailing market conditions.


Data Analysis and Market Size Estimation


The market size of the global NGS market is estimated using different quantitative methodologies, based on primary research, market survey, desk-based research and industry reports. The data is collected from various contributors and is analyzed and the market size is estimated based on product type, application, end-user and geographical segmentation. The market forecasts for 2023-2030 are provided, considering the expected market growth of the NGS technology and its applications.


Conclusion


Through this comprehensive research methodology, the report endeavours to provide an in-depth and comprehensive understanding of the NGS technology and its various components. The research methodology is expected to provide insights into the current market conditions, technological advancements, market trends and dynamics, competitive landscape, and other market insights. The data collected and analyzed through this process is expected to enable stakeholders to make informed decisions and plan strategies to capitalize on the opportunities prevailing within the NGS market.

Speak to Analyst